| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 06/17/2004 | WO2004050630A1 The use of aryl- and heteroaryl-substituted tetrahydroisoquinolines in the treatment of chronic and neuropathic pain, migraine headaches, and urge, stress and mixed urinary incontinence |
| 06/17/2004 | WO2004050624A1 Substituted 1h-pyridine-2-one derivatives |
| 06/17/2004 | WO2004050621A2 Indol derivatives and their use as kinase inhibitors |
| 06/17/2004 | WO2004050619A1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease |
| 06/17/2004 | WO2004050613A2 2-substituted-3-propenamide derivatives and methods of using the same |
| 06/17/2004 | WO2004050609A1 Substituted ureas and carbamates |
| 06/17/2004 | WO2004050087A1 3-(2-hydroxy-phenyl)-1h-pyrazole-4-carboxylic acid amide derivatives as hsp90 inhibitors for the treatment of cancer |
| 06/17/2004 | WO2004050082A1 The novel coumarin-amide derivatives and its preparation, said drug composition and its use |
| 06/17/2004 | WO2004050035A2 Benzimidazoles and analogs thereof as antivirals |
| 06/17/2004 | WO2004050024A2 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 06/17/2004 | WO2004050018A2 Dicationic 2,5-diarylfuran aza-analogs as anti-protozoan agents |
| 06/17/2004 | WO2004049797A2 Pesticidal sulphonylaminopyrazoles |
| 06/17/2004 | WO2004018414A3 Antibacterial agents |
| 06/17/2004 | WO2004014869A3 5,6-fused 3,4-dihydropyrimidine-2-one derivatives as matrix metalloproteinase inhibitors |
| 06/17/2004 | WO2003105781A3 Ophthalmic compositions for treating ocular hypertension |
| 06/17/2004 | US20040116710 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 06/17/2004 | US20040116706 Therapeutic ureas |
| 06/17/2004 | US20040116695 2-Mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors |
| 06/17/2004 | US20040116694 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 06/17/2004 | US20040116507 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 06/17/2004 | US20040116499 treatment of inflammatory or proliferative diseases of the skin and other organ systems; from yeast of the genus Malassezia; for example, 2,3-dihydro-4,5-bis(indol-3-yl)furan-2,3-dione; against multiresistent staphylococci |
| 06/17/2004 | US20040116497 Chromane derivatives, process for their preparation and their use as antitumor agents |
| 06/17/2004 | US20040116491 Therapy for infections; autoimmune diseases; vision defects; asthma:eating disorders; cardiovascular disorders; liver disorders; antiallergens; antiinflammatory agents; antiulcer agnets |
| 06/17/2004 | US20040116486 Metalloproteinase inhibitors |
| 06/17/2004 | US20040116480 Oxime ether compound and agricultural or horticultural bactericide |
| 06/17/2004 | US20040116476 Imidazolidinone compounds |
| 06/17/2004 | US20040116474 Novel pyrazole compounds as transforming growth factor (TGF) inhibitors |
| 06/17/2004 | US20040116472 inhibit angiogenesis, tumor metastasis and growth, osteoporosis, Paget's disease, hypercalcemia of malignancy, retinopathy, macular degeneration, arthritis, periodontal disease, smooth muscle cell migration and viral diseases |
| 06/17/2004 | US20040116471 Indolylpiperidine derivatives as antihistaminic aand antiallergic agents |
| 06/17/2004 | US20040116465 Novel compounds |
| 06/17/2004 | US20040116455 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/17/2004 | US20040116454 Pyrazole compounds useful as protein kinase inhibitors |
| 06/17/2004 | US20040116443 Dopamine D4 ligands for the treatment of novelty-seeking disorders |
| 06/17/2004 | US20040116440 Useful for diagnosis, treatment of male or female sexual dysfunction |
| 06/17/2004 | US20040116431 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 06/17/2004 | US20040116424 Aryl imidazoles and related compounds as C5a receptor modulators |
| 06/17/2004 | US20040116423 5-Aryltetrazole compounds, compositions thereof, and uses therefor |
| 06/17/2004 | US20040116422 Drugs as enzyme inhibitors for tyrosine kinases and for treatment of psoriasis |
| 06/17/2004 | US20040116420 Remedial agent for viral infectious disease |
| 06/17/2004 | US20040116417 Thiohydantoins and use thereof for treating diabetes |
| 06/17/2004 | US20040116399 for preventing or treating coagulation disorders |
| 06/17/2004 | US20040116388 triazine compoound inhibitors of enzymes that catalyze phosphoryl transfer and/or that bind ATP/GTP nucleotides |
| 06/17/2004 | US20040116353 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 06/17/2004 | DE19742593B4 Neuer farbbildender Farbstoffvorläufer, Zusammensetzung, die denselben enthält und farbbildendes wärmeempfindliches Aufzeichnungsmaterial New color-forming dye precursor composition comprising the same and color-forming heat-sensitive recording material |
| 06/17/2004 | DE10256405A1 New 4-substituted quinoline derivatives, useful for treating bacterial infections, optionally including additional ring nitrogens |
| 06/17/2004 | DE10247233A1 New 4-substituted quinoline derivatives, useful for treating bacterial infections, optionally including additional ring nitrogens |
| 06/17/2004 | CA2508574A1 3-(2-hydroxy-phenyl)-1h-pyrazole-4-carboxylic acid amide derivatives as hsp90 inhibitors for the treatment of cancer |
| 06/17/2004 | CA2508329A1 Substituted dihydrophenanthridinesul fonamides |
| 06/17/2004 | CA2508325A1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease |
| 06/17/2004 | CA2507780A1 Indol derivatives and their use as kinase inhibitors |
| 06/17/2004 | CA2507484A1 Substituted ureas and carbamates |
| 06/17/2004 | CA2505893A1 Oxime ester photoinitiators with heteroaromatic groups |
| 06/17/2004 | CA2504742A1 Process for synthesis bis-aryl diamidoxime compounds |
| 06/17/2004 | CA2504740A1 Dicationic 2,5-diarylfuran aza-analogs as anti-protozoan agents |
| 06/16/2004 | EP1428822A2 1-phenylpiperazine derivative as modulators of dopamine neurotransmission |
| 06/16/2004 | EP1427724A1 Novel use of substituted aminomethyl chromans |
| 06/16/2004 | EP1427723A1 Tetrahydropyran derivatives and their use as therapeutic agents |
| 06/16/2004 | EP1427722A2 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression |
| 06/16/2004 | EP1427708A1 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 06/16/2004 | EP1427707A1 Substituted indazole compounds for the treatment of inflammation |
| 06/16/2004 | EP1427421A1 2,4-disubstituted pyrimidinyl derivatives for use as anticancer agents |
| 06/16/2004 | EP1427417A1 3-substituted 6,7-dihydroxytetrahydroisoquinoline derivatives for use as antibacterial agents |
| 06/16/2004 | EP1427416A2 3-glyoxlylamideindoles for treating cancer |
| 06/16/2004 | EP1427408A2 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-$g(a) CONVERTING ENZYME (TACE) |
| 06/16/2004 | EP1427407A2 Fatty amine drug conjugates |
| 06/16/2004 | EP1351958B1 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 06/16/2004 | EP1341763B1 N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization |
| 06/16/2004 | EP1339406B1 Piperazine derivatives, their preparation and their use for treating central nervous system (cns) disorders |
| 06/16/2004 | EP1282616B1 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatement of pain |
| 06/16/2004 | EP1263751B1 2-phenylpyran-4-one derivatives |
| 06/16/2004 | EP1255751B1 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b or v1b and v1a arginine-vasopressin receptors |
| 06/16/2004 | EP1219173B1 Insecticides and acaricides |
| 06/16/2004 | EP1214074B1 Dioxolane nucleoside analogs for the treatment or prevention of viral infection |
| 06/16/2004 | EP1194411B1 Benzoylpyridazines |
| 06/16/2004 | EP1147083B1 Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression |
| 06/16/2004 | EP0983243B1 Novel quinoline- and naphthalenecarboxamides, pharmaceutical compositions and methods of inhibiting calpain |
| 06/16/2004 | EP0979079B1 Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination |
| 06/16/2004 | EP0960104B1 N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-one derivatives as factor xa inhibitors |
| 06/16/2004 | EP0823423B1 1,4-disubstituted piperidine derivatives |
| 06/16/2004 | CN1505628A Triazole compounds useful in treating diseases associated with unwanted cytokine activity |
| 06/16/2004 | CN1505625A Triazole compounds useful in treating diseases associated with unwanted cytokine activity |
| 06/16/2004 | CN1505624A Piperazino-derivatives and their use as pde4 inhibitor |
| 06/16/2004 | CN1505617A Peptides as met-ap2 inhibitors |
| 06/16/2004 | CN1505613A Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppar-gamma binding agents |
| 06/16/2004 | CN1505514A Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors |
| 06/16/2004 | CN1504462A Pyrimidinyl derivatives as interleukin inhibitors |
| 06/16/2004 | CN1153770C Substitued nitrogen heterocyclic ring as inhibitors of P38 protein kinase |
| 06/16/2004 | CN1153766C Nitroketone compound, its preparing process and pharmaceutical composition containing same |
| 06/16/2004 | CN1153764C Substituted benzylaminopiperidine compounds |
| 06/15/2004 | US6750357 Rhodamine-based fluorophores useful as labeling reagents |
| 06/15/2004 | US6750353 Preparation of pharmaceutically acceptable atorvastatin salts in non-crystalline form |
| 06/15/2004 | US6750349 Superior gastrokinetic properties |
| 06/15/2004 | US6750348 Protective effects against infection by hiv through binding to chemokine receptors, including cxcr4 and ccr5;n-(2-pyridinylmethyl)-n'-(2-(phenylureido)ethyl)-n'-(5,6,7,8-tetrahydro-8-quinolinyl)-1,4-benzenedimethanamine |
| 06/15/2004 | US6750346 Chromenes as terminal end groups |
| 06/15/2004 | US6750338 Process for making 5-substituted pyrazoles |
| 06/15/2004 | US6750254 Nitric oxide-releasing amidine—and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 06/15/2004 | US6750245 C7 carbamate substituted taxanes |
| 06/15/2004 | US6750243 COMPETITIVE INHIBITORS OF TRYPSIN-LIKE SERINE PROTEASES, ESPECIALLY THROMBIN; chemical synthesis; anticoagulants; treatment of thrombosis |
| 06/15/2004 | US6750242 Positive modulators of nicotinic receptor agonists |
| 06/15/2004 | US6750241 Two or more ligand moieties covalently linked together by one or more linking groups enabling binding to multiple binding sites; increased efficacy, selectivity and duration; anti-proliferative and anticarcinogenic |